相关实验视频
Updated: Sep 16, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.8K
一种具有多功能作用的新型重组低血糖蛋白的制备,表征和功能评估
Tianzhu Liu1,2,3, Xiaoxuan Ma1,2,3, Zhiguang Duan1,2,3
1Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Ministry of Education, School of Chemical Engineering, Northwest University, Xi'an 710069, China.
Journal of agricultural and food chemistry
|July 8, 2025
概括
来自人参的新型重组低血糖蛋白 (RHP) 显示出糖尿病治疗的前景. RHP抑制关键酶并改善细胞中的胰岛素敏感性,为药物开发提供了一条新的途径.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 广泛使用低血糖药物导致显著的耐药性.
- 迫切需要新的低血糖药物和治疗策略.
- 糖尿病管理需要在药物发现方面不断创新.
研究的目的:
- 开发一种新型的重组低血糖蛋白 (RHP).
- 研究RHP对α-葡萄糖酶 (α-GC) 和α-氨基酶 (α-AL) 的抑制作用.
- 为了评估RHP在减轻胰岛素耐药性的有效性在体外.
主要方法:
- 基因工程和多重复制合技术被用来准备RHP.
- 进行了生物化学测试,以评估RHP对α-GC和α-AL的抑制活性.
- 使用HepG2细胞进行了基于细胞的体外实验,以评估RHP对胰岛素耐药性的影响.
主要成果:
- RHP对α-葡萄糖酶和α-氨基酶都表现出显著的抑制作用.
- 特定的氨基酸残留物 (Thr,Gly,Glu) 被认为对RHP的作用机制至关重要.
- 在HepG2细胞中RHP治疗增加了葡萄糖吸收,减少了活性氧物种,并恢复了线粒体功能,缓解了胰岛素抵抗.
结论:
- 小说RHP表现出强大的低血糖和胰岛素敏感性质.
- RHP代表了开发新的抗糖尿病药物或功能性食品的有希望的候选人.
- 这项研究为糖尿病管理中的未来治疗应用提供了坚实的基础.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
569
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
569
Glucagon-like Receptor Agonists
431
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
431
Hypoglycemia and Glucagon
349
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
349
Oral Hypoglycemic Agents: Glinides
269
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
269
Recombinant DNA
96.8K
Overview
96.8K
Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K

